INTRODUCTION
Chromaffin cells contain chromogranin A (CgA) which is costored and coreleased with catecholamines from storage granules in the adrenal medulla; this granin plays a catalytic role in granule biogenesis (1). Konecki et al. (2) isolated a full-length clone encoding human CgA from a cDNA library of a human pheochromocytoma. The nucleotide sequence showed that human CgA is a 439 amino acid protein preceded by an 18-residue signal peptide.
CgA is present in the secretory granules of a wide variety of endocrine and neuroendocrine cells with numerous pairs of basic amino acids as potential cleavage site (2) . CgA is secreted by a great variety of peptideproducing endocrine neoplasms such as pheochromocytoma, parathyroid adenoma, medullary thyroid carcinoma, carcinoids, oatcell lung cancer, pancreatic islet-cell tumors, and aorticbody tumor (3). Nobels et al. (4) evaluated the clinical usefulness of CgA as a neuroendocrine serum marker; CgA was increased in 50 % of patients with neuroendocrine tumors and most frequently increased in subjects with gastrinomas (100 %), pheochromocytomas (89 %), carcinoid tumors (80 %), nonfunctioning tumors of the endocrine pancreas (69 %), and medullary thyroid carcinomas (50 %) (4) . Measuring plasma CgA is a useful complementary test when evaluating patients with adrenal incidentalomas and presumed pheochromocytomas (5 (9) .
Most of the reported measurement of CgA by radioimmunoassay utilized native CgA antigens (full or partial length) and antibodies against the native proteins. Yanaihara et al. provided a novel radioimmunoassay system for estimation of CgA-LI level in human plasma with use of synthetic human CgA (344-374) and antibody raised against the synthetic peptide. In the adrenal medulla which is the major site of CgA production, CgA is found to exist predominantly in large molecular forms, supporting the least processing of CgA in adrenal chromaffin cells. In addition, it was shown that there is no rapid degradation of the protein within the blood stream (10) .
On the basis of these findings, Yanaihara Institute Inc. succeeded in developing, for the first time, a specific and sensitive enzyme immunoassay system for measurement of human CgA-LI using anti-synthetic human CgA (344-374) antibody, synthetic human CgA (344-374) as standard antigen and N-biotinylglycylglycyl human CgA (344-374) as labeled antigen.
Keeping in mind these findings we tried to prove by our study if salivary chromogranin A (CgA-LIS) could be a substitute for classical plasma CgA in pheochromocytoma diagnosis.
PATIENTS AND METHODS
This retrospective study included a group of 10 pheochromocytoma cases: 7 women aged: 22-72 years and 3 men aged: 42-59 years, admitted and diagnosed in our institute between 2009-2010 and a 10 control group: 10 healthy women (without endocrine disfunction) aged 25-48 years. This study was approved by the Ethics Committee of our Institute. All subjects gave their informed consent before starting this study.
Sampling: All subjects collected in the morning at 9 am (after an overnight fasting, free of drugs) a sample of plasma (in EDTA vacutainer) for free metanephrines and CgA assay and a salivary sample (2 minutes collection time) in a Sallivette Cortisol, code blue from Sarstedt Company for salivary CgA. After centrifugation, plasma and saliva samples were aliquoted and stored at -18° C until assayed.
Assays: Free plasma NMN and MN were differentially assayed by Elisa Fast track kits from LDN GmbH with a limit of detection (analytical sensitivity) of 15 pg/mL for NMNp and 10 pg/mL for MNp. Intra-assay precision for NMNp was: CV%≤7.5 and inter-assay was: CV% ≤ 7.1; intra-assay precision for MNp was: CV% ≤ 10 and interassay was: CV% ≤ 9.5. Reference interval based on normal distribution (95 % double sided) and established by our lab was: NMNp: 15.61-129.87 pg/mL and MNp: 11.01-41.51 pg/mL. Plasma CgA was detected by an Elisa kit from LDN GmbH. Assay characteristics revealed: limit of detection:10ng/mL, intra-assay precision: CV%:8.9, inter-assay precision: CV%:9.5. Reference interval based on normal distribution (95% double sided) and established by our lab was: 43.14-121.23 ng/mL. Salivary CgA was assayed by an EIA kit from Cosmo Bio Co.,LTD. Intra-assay precision was: CV%<12, and inter-assay precision was CV%<14. Limit of detection was: <0.14 pmol/mL. Reference interval based on normal distribution (95%-double sided) and established by our lab was: 0.13-3.77 pmol/mL. All plasma and saliva samples were assayed in duplicate and results were expressed as mean ± SEM. Statistical analysis was performed using Med Calc Software version 8.0.0.1. Windows 98/ NT/ Me/2000/XP.
RESULTS
Some clinical data concerning tumoral cases diagnosed in our institute during 2009-2010 are included in Table 1 . Mean values for all 4 parameters were compared in both groups: tumoral and normal by t-test. All parameters differ significantly in tumoral group in comparison to control group ( Table 2) .
All parameters showed a normal distribution evaluated by KolmogorovSmirnov test in both groups. We established significant positive correlations between different parameters: NMNp and MNp, NMNp and CgA, NMNp and CgA-LIS and between CgA and CgA-LIS (Table 3 ). The best correlations were established between NMNp and MNp and between NMNp and CgA-LIS. We used multiple regression to analyse the relationship between CgA-LIS as dependent variable and NMNp, MNp, CgA as independent variables. All data are included in Table 4 .
Regression equation showed that all 3 independent variables contribute significantly to the prediction of the dependent variable: CgA-LIS. The (Fig.1, Table 6 ). NMNp and CgA-LIS proved the best sensitivity with high negative predictive values. Pairwise comparison of ROC curves revealed no significant differences between different parameters areas (Table 7) .
DISCUSSION
As a general rule, pheochromocytomas are first established by a sensitive biochemical diagnosis and then confirmed by specific imaging studies. The measurement of plasma metanephrines is extremely sensitive and some have advocated its use as a first-line test (11) . In our study, NMNp showed the best sensitivity and 1, 2, 3, 4 , 5, 6, 7, 10) and salivary CgA-LIS in all 10 cases. CgA-LIS seems more sensitive than plasma CgA and showed high negative predictive values. Besides NMNp, salivary CgA-LIS seems the second test of choice for pheochromocytoma diagnosis and we estimated a high significant correlation between these two parameters.
The correlation between saliva and serum CgA is not yet well understood (12) (13) (14) . Peptides of salivary glandular origin are secreted by exocytosis directly in the acinar lumen. An active, energy-dependent mode of transport causes difficulties in interpreting the salivary concentrations because concentrations of salivary peptides do not always correlate as well with plasma concentrations as do concentrations of passively diffused steroids (15) .
CgA-LIS in humans is produced by submandibular gland and secreted into saliva. Western blotting gave one significant immunoreactive band of 68 kDa in the adrenal gland, human submandibular gland and saliva (16) . However, expression of CgA is poorly understood in humans, although salivary gland localization of CgA in other mammals, such as rodents and horses, has been demonstrated. CgA-LI is stored in the cells of granular convoluted tubule and is secreted into saliva by stimulation with nicotinamide adenine dinucleotide (NAD) in the isolated and perfused rat submandibular gland. The cells may release CgA-LI into blood stream (endocrine secretion) in addition to salivary release (exocrine secretion). The endocrine exocrine secretion of the cells resembles the secretion of renin in the cells of juxtaglomerular apparatus and coagulating gland (17) . In a recent study, the authors found similar concentrations of CgA in serum and saliva (18) .
In our study, from analytical point of view there is no difference between plasma and saliva CgA values; Cusum test revealed no significant deviation from linearity. On the other hand, ROC analysis showed no significant difference between areas of these parameters. In spite of a restrained number of subjects included in this study, we pointed out the importance of CgA-LIS as a complementary parameter in pheochromocytoma diagnosis proving both analytical and diagnostic performance. To our knowledge, our study is the first concerning the utility of salivary CgA in pheochromocytoma diagnosis. We can conclude that a correct biochemical algorithm for pheochromocytoma diagnosis could include both free plasma metanephrines and salivary chromogranin A with better performance of saliva than plasma chromogranin. The convenience of rapid short-interval sampling and the availability of non-protein bound hormones are the main advantages of salivary analysis. Salivary CgA-LIS could precise pheochromocytoma diagnosis in a non-aggressive manner for the patient using saliva instead of plasma samples.
In conclusion, our study proved the importance of salivary CgA as a complementary marker with high analytical and diagnostic performance in clinical diagnosis of pheochromocytoma.
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